• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表皮生长因子(EGF)、转化生长因子-α(TGF-α)及表皮生长因子受体(EGFR)在肺鳞状细胞癌中的表达

Expression of EGF, TGF-alpha and EGFR in squamous cell lung carcinomas.

作者信息

Gorgoulis V, Aninos D, Mikou P, Kanavaros P, Karameris A, Joardanoglou J, Rasidakis A, Veslemes M, Ozanne B, Spandidos D A

机构信息

Red Cross Hospital, Athens, Greece.

出版信息

Anticancer Res. 1992 Jul-Aug;12(4):1183-7.

PMID:1503407
Abstract

Immunohistochemical study of epidermal growth factor (EGF), epidermal growth factor receptor (EGFR) and transforming growth factor-alpha (TGF-alpha) expression was performed on paraffin-embedded tissue specimens of 70 squamous cell lung carcinomas. The carcinomas were placed to one of the following eight groups, according to the results of EGF, TGF-alpha and EGFR expression: group 1: none, group 2: only EGFR, group 3: EGFR and TGF-alpha, group 4: EGFR and EGF, group 5: TGF-alpha and EGF, group 6: all three, group 7: only TGF-alpha and finally group 8: only EGF. Statistical analysis of the results revealed that the ratio of squamous cell lung carcinomas with lymph node metastasis was significantly higher in groups 4, 5 and 6 (P less than 0.01). We also examined whether EGF receptors were truncated with the use of two monoclonal antibodies directed against different portions of the receptor (EGFR1 and F4). No truncated EGF receptors were detected. These results suggest that lung carcinomas expressing the molecules EGF/EGFR, TFG-alpha/EGFR or TGF/alpha/EGF/EGFR display pathologic features of more aggressive disease.

摘要

对70例肺鳞状细胞癌石蜡包埋组织标本进行了表皮生长因子(EGF)、表皮生长因子受体(EGFR)和转化生长因子-α(TGF-α)表达的免疫组织化学研究。根据EGF、TGF-α和EGFR表达结果,将这些癌组织分为以下八组之一:第1组:无表达,第2组:仅EGFR表达,第3组:EGFR和TGF-α表达,第4组:EGFR和EGF表达,第5组:TGF-α和EGF表达,第6组:三者均表达,第7组:仅TGF-α表达,最后第8组:仅EGF表达。结果的统计学分析显示,第4、5和6组中发生淋巴结转移的肺鳞状细胞癌比例显著更高(P<0.01)。我们还使用针对受体不同部分的两种单克隆抗体(EGFR1和F4)检测了EGF受体是否被截断。未检测到截断的EGF受体。这些结果表明,表达EGF/EGFR、TFG-α/EGFR或TGF/α/EGF/EGFR分子的肺癌表现出更具侵袭性疾病的病理特征。

相似文献

1
Expression of EGF, TGF-alpha and EGFR in squamous cell lung carcinomas.表皮生长因子(EGF)、转化生长因子-α(TGF-α)及表皮生长因子受体(EGFR)在肺鳞状细胞癌中的表达
Anticancer Res. 1992 Jul-Aug;12(4):1183-7.
2
Expression of epidermal growth factor, transforming growth factor-alpha and epidermal growth factor receptor in thyroid tumors.表皮生长因子、转化生长因子-α及表皮生长因子受体在甲状腺肿瘤中的表达
In Vivo. 1992 May-Jun;6(3):291-6.
3
The epidermal growth factor family in pulmonary carcinoids: immunohistochemical evidence of growth-promoting circuits.肺类癌中的表皮生长因子家族:促进生长回路的免疫组化证据
Mod Pathol. 1993 Mar;6(2):162-6.
4
Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression.表皮生长因子受体及其配体转化生长因子α的过表达在可切除的非小细胞肺癌中很常见,但不能预测肿瘤进展。
Clin Cancer Res. 1997 Apr;3(4):515-22.
5
Transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor expression in normal and diseased human adrenal cortex by immunohistochemistry and in situ hybridization.通过免疫组织化学和原位杂交检测正常及病变人类肾上腺皮质中转化生长因子α、表皮生长因子及表皮生长因子受体的表达
Mod Pathol. 1994 Sep;7(7):741-6.
6
Immunoreactive transforming growth factor alpha and epidermal growth factor in oral squamous cell carcinomas.口腔鳞状细胞癌中的免疫反应性转化生长因子α和表皮生长因子
J Pathol. 1993 Mar;169(3):323-8. doi: 10.1002/path.1711690308.
7
Epidermal growth factor receptor and transforming growth factor alpha expression in papillary and nonpapillary renal cell carcinoma: correlation with metastatic behavior and prognosis.表皮生长因子受体和转化生长因子α在乳头状和非乳头状肾细胞癌中的表达:与转移行为和预后的相关性
Clin Cancer Res. 1995 Aug;1(8):913-20.
8
Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung.表皮生长因子受体及其配体在原发性非小细胞肺癌及邻近肺良性组织中的差异表达
Cancer Res. 1993 May 15;53(10 Suppl):2379-85.
9
Aberrant expression of p53 or the epidermal growth factor receptor is frequent in early bronchial neoplasia and coexpression precedes squamous cell carcinoma development.p53或表皮生长因子受体的异常表达在早期支气管肿瘤中很常见,且共表达先于鳞状细胞癌的发生。
Cancer Res. 1995 Mar 15;55(6):1365-72.
10
Asynchronous modulation of transforming growth factor alpha and epidermal growth factor receptor protein expression in progression of premalignant lesions to head and neck squamous cell carcinoma.在癌前病变进展为头颈部鳞状细胞癌过程中转化生长因子α和表皮生长因子受体蛋白表达的异步调节
Clin Cancer Res. 1998 Jan;4(1):13-20.

引用本文的文献

1
Prognostic Significance of HER3 Expression in Patients with Cervical Cancer.HER3表达在宫颈癌患者中的预后意义
Cancers (Basel). 2022 Apr 25;14(9):2139. doi: 10.3390/cancers14092139.
2
Knockdown of Gene Expression in Macrophages by microRNA Mimic-Containing Poly (Lactic--glycolic Acid) Microparticles.含微小RNA模拟物的聚(乳酸-乙醇酸)微粒对巨噬细胞基因表达的敲低作用
Medicines (Basel). 2018 Dec 15;5(4):133. doi: 10.3390/medicines5040133.
3
Signal reachability facilitates characterization of probabilistic signaling networks.
信号可达性有助于概率信号网络的特征描述。
BMC Bioinformatics. 2015;16 Suppl 17(Suppl 17):S6. doi: 10.1186/1471-2105-16-S17-S6. Epub 2015 Dec 7.
4
Prolactinoma ErbB receptor expression and targeted therapy for aggressive tumors.催乳素瘤 erbB 受体表达和侵袭性肿瘤的靶向治疗。
Endocrine. 2014 Jun;46(2):318-27. doi: 10.1007/s12020-013-0093-x. Epub 2013 Nov 28.
5
Nonviral gene therapy in vivo with PAM-RG4/apoptin as a potential brain tumor therapeutic.PAM-RG4/apoptin 作为一种潜在的脑肿瘤治疗药物的体内非病毒基因治疗。
Int J Nanomedicine. 2013;8:821-34. doi: 10.2147/IJN.S39072. Epub 2013 Feb 25.
6
Vaccine strategies for glioblastoma: progress and future directions.脑胶质瘤的疫苗策略:进展与未来方向。
Immunotherapy. 2013 Feb;5(2):155-67. doi: 10.2217/imt.12.155.
7
Molecular mechanisms of cardiotoxicity induced by ErbB receptor inhibitor cancer therapeutics.表皮生长因子受体(ErbB)抑制剂类癌症治疗药物所致心脏毒性的分子机制
Int J Mol Sci. 2012 Sep 26;13(10):12268-86. doi: 10.3390/ijms131012268.
8
Targeting non-malignant disorders with tyrosine kinase inhibitors.用酪氨酸激酶抑制剂靶向非恶性疾病。
Nat Rev Drug Discov. 2010 Dec;9(12):956-70. doi: 10.1038/nrd3297.
9
Design, synthesis, and X-ray crystal structures of 2,4-diaminofuro[2,3-d]pyrimidines as multireceptor tyrosine kinase and dihydrofolate reductase inhibitors.设计、合成和 2,4-二氨基呋喃并[2,3-d]嘧啶的 X 射线晶体结构作为多受体酪氨酸激酶和二氢叶酸还原酶抑制剂。
Bioorg Med Chem. 2009 Oct 15;17(20):7324-36. doi: 10.1016/j.bmc.2009.08.044. Epub 2009 Aug 22.
10
Pathway-based evaluation of 380 candidate genes and lung cancer susceptibility suggests the importance of the cell cycle pathway.基于通路对380个候选基因与肺癌易感性的评估表明细胞周期通路的重要性。
Carcinogenesis. 2008 Oct;29(10):1938-43. doi: 10.1093/carcin/bgn178. Epub 2008 Aug 1.